- Home
- MRVI vs SKYH Comparison
MRVI vs SKYH Comparison
Compare MRVI & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- SKYH
- Stock Information
- Founded
- MRVI 2014
- SKYH 2017
- Country
- MRVI United States
- SKYH United States
- Employees
- MRVI 560
- SKYH N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- SKYH Military/Government/Technical
- Sector
- MRVI Health Care
- SKYH Industrials
- Exchange
- MRVI Nasdaq
- SKYH Nasdaq
- Market Cap
- MRVI 350.1M
- SKYH 325.2M
- IPO Year
- MRVI 2020
- SKYH N/A
- Fundamental
- Price
- MRVI $2.42
- SKYH $10.52
- Analyst Decision
- MRVI Hold
- SKYH Strong Buy
- Analyst Count
- MRVI 10
- SKYH 3
- Target Price
- MRVI $5.84
- SKYH $14.83
- AVG Volume (30 Days)
- MRVI 1.5M
- SKYH 104.9K
- Earning Date
- MRVI 08-11-2025
- SKYH 08-12-2025
- Dividend Yield
- MRVI N/A
- SKYH N/A
- EPS Growth
- MRVI N/A
- SKYH N/A
- EPS
- MRVI N/A
- SKYH N/A
- Revenue
- MRVI $219,830,000.00
- SKYH $20,919,000.00
- Revenue This Year
- MRVI N/A
- SKYH $124.39
- Revenue Next Year
- MRVI $7.23
- SKYH $83.05
- P/E Ratio
- MRVI N/A
- SKYH N/A
- Revenue Growth
- MRVI N/A
- SKYH 94.38
- 52 Week Low
- MRVI $1.67
- SKYH $9.28
- 52 Week High
- MRVI $9.60
- SKYH $14.52
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- SKYH 52.98
- Support Level
- MRVI $2.28
- SKYH $10.20
- Resistance Level
- MRVI $2.47
- SKYH $10.89
- Average True Range (ATR)
- MRVI 0.14
- SKYH 0.40
- MACD
- MRVI -0.01
- SKYH 0.02
- Stochastic Oscillator
- MRVI 27.45
- SKYH 46.43
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.